Aarey Drugs & Pharmaceuticals Hits Upper Circuit Limit Amid Positive Market Momentum
Aarey Drugs & Pharmaceuticals Ltd experienced notable trading activity today, reaching its upper circuit limit and closing higher. The stock has gained for four consecutive days, outperforming its sector while the broader market declined slightly. Despite a decrease in delivery volume, it remains above key moving averages, indicating strong performance.
Aarey Drugs & Pharmaceuticals Ltd, a microcap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 58.89, reflecting a 4.21% increase, and closed at Rs 56.67, marking an absolute change of 2.69 and a percentage change of 4.98. The stock has been on a positive trajectory, gaining for the last four consecutive days, with a total return of 5.69% during this period. Today's performance outpaced the sector by 0.45%, while the broader market, represented by the Sensex, saw a slight decline of 0.12%.
Aarey Drugs recorded a total traded volume of approximately 0.71 lakh shares, resulting in a turnover of Rs 0.396 crore. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance trend. However, it is worth noting that delivery volume has decreased by 37.83% compared to the 5-day average.
Overall, Aarey Drugs & Pharmaceuticals Ltd has demonstrated robust performance today, reflecting positive momentum in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
